We are live on
!
Find out more
HMC
Harvard Management Company Portfolio holdings
AUM
$1.82B
1-Year Est. Return
26.23%
This Fund
S&P 500
This Quarter
Est. Return
+23.18%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.02B
AUM Growth
+$67.1M
(+7%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-12.11%
Top 10 Holdings %
Top 10 Hldgs %
94.35%
Holding
48
New
–
Increased
5
Reduced
8
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$8.85M |
| 2 |
Advanced Micro Devices
AMD
|
+$5.75M |
| 3 |
PCTTW
PureCycle Technologies Inc Warrant
PCTTW
|
+$5.57M |
| 4 |
ASML
ASML
|
+$4.99M |
| 5 |
Pacific Biosciences
PACB
|
+$49.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbCellera Biologics
ABCL
|
+$31M |
| 2 |
PureCycle Technologies
PCT
|
+$12.9M |
| 3 |
Applied Materials
AMAT
|
+$10.9M |
| 4 |
Analog Devices
ADI
|
+$10.8M |
| 5 |
Qorvo
QRVO
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 60.33% |
| 2 | Consumer Discretionary | 18.08% |
| 3 | Technology | 12.76% |
| 4 | Healthcare | 5.21% |
| 5 | Industrials | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Meta Platforms (Facebook)
META
$1.51T
| $326M | 31.99% |
1,135,916
| – | – |
|
2
Alphabet (Google) Class A
GOOGL
$3.91T
| $289M | 28.33% |
2,411,540
| – | – |
|
|
LNW
3
DELISTED
Light & Wonder
LNW
| $184M | 18.08% |
2,678,571
| – | – |
|
4
Grab
GRAB
$13.5B
| $44.7M | 4.39% |
13,036,482
| – | – |
|
|
PCTTW
5
PureCycle Technologies Inc Warrant
PCTTW
$9.5M
| $26.7M | 2.62% |
2,498,170
+1,783,885
| +250% | +$5.57M |
|
6
NVIDIA
NVDA
$5.01T
| $21.3M | 2.09% |
502,890
-160,790
| -24% | -$5.34M |
|
|
7
TSMC
TSM
$2.09T
| $20.4M | 2% |
202,347
+95,053
| +89% | +$8.85M |
|
|
8
ASML
ASML
$675B
| $19.9M | 1.96% |
27,519
+7,333
| +36% | +$4.99M |
|
|
9
Advanced Micro Devices
AMD
$851B
| $19.1M | 1.87% |
167,406
+55,269
| +49% | +$5.75M |
|
10
10x Genomics
TXG
$5.87B
| $10.4M | 1.02% |
186,143
| – | – |
|
|
EQRX
11
DELISTED
EQRx, Inc. Common Stock
EQRX
| $7.17M | 0.7% |
3,853,367
| – | – |
|
12
Recursion Pharmaceuticals
RXRX
$1.57B
| $6.59M | 0.65% |
882,129
-627,125
| -42% | -$4.39M |
|
13
Rocket Lab Corp
RKLB
$39.9B
| $6M | 0.59% |
1,000,000
| – | – |
|
|
CFLT
14
DELISTED
Confluent
CFLT
| $4.6M | 0.45% |
130,383
| – | – |
|
15
Tenaya Therapeutics
TNYA
$168M
| $3.95M | 0.39% |
673,270
| – | – |
|
16
Nurix Therapeutics
NRIX
$2.43B
| $3.14M | 0.31% |
314,762
| – | – |
|
|
17
PureCycle Technologies
PCT
$1.17B
| $3.14M | 0.31% |
714,285
-1,783,885
| -71% | -$12.9M |
|
|
18
Pacific Biosciences
PACB
$422M
| $3.1M | 0.3% |
233,186
+4,042
| +2% | +$49.1K |
|
|
GBIO
19
DELISTED
Generation Bio
GBIO
| $2.81M | 0.28% |
51,035
| – | – |
|
20
Sana Biotechnology
SANA
$885M
| $2.79M | 0.27% |
468,749
| – | – |
|
|
VIGL
21
DELISTED
Vigil Neuroscience
VIGL
| $2.72M | 0.27% |
289,460
| – | – |
|
22
Tango Therapeutics
TNGX
$4.34B
| $2.35M | 0.23% |
708,385
| – | – |
|
|
KNTE
23
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $1.4M | 0.14% |
462,418
-35,583
| -7% | -$137K |
|
|
DBTX
24
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $1.25M | 0.12% |
326,029
-2,769
| -0.8% | -$10.2K |
|
25
Fulcrum Therapeutics
FULC
$248M
| $1.13M | 0.11% |
341,972
-68,742
| -17% | -$202K |
|
Similar funds
DWT
MCC
ST
DE
SI
WIC
GC
RHJA
Harvard Management Company's Q2 2023 Portfolio in Review
As of Q2 2023, Harvard Management Company held 48 positions worth $1.02B, up 7% from $952M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Harvard Management Company withdrew a net $123M in Q2 2023, closing 15 positions and reducing 8 holdings. Its most notable exit was AbCellera Biologics, an estimated $31M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 60% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Harvard Management Company added an estimated $8.85M to TSMC.
- Harvard Management Company added most to TSMC in Q2 2023, an estimated $8.85M increase.
- Harvard Management Company's biggest Q2 2023 reduction was PureCycle Technologies, cutting an estimated $12.9M.
- Harvard Management Company fully exited AbCellera Biologics in Q2 2023, selling an estimated $31M.
- Harvard Management Company's ten largest holdings make up 94% of its $1.02B portfolio in Q2 2023.
- Harvard Management Company opened 0 new positions and closed 15 in Q2 2023.
- Harvard Management Company's portfolio value rose 7% quarter-over-quarter to $1.02B.
Based on Harvard Management Company's 13F filing for Q2 2023, filed 11 Aug 2023.